EBV VCA IgG Kit ELISA

N° du produit ABIN1326837

Le kit ELISA EBV VCA IgG (ABIN1326837) Humain est un kit ELISA Colorimetric conçu pour quantifier Humain EBV VCA IgG. Ce kit ELISA a été cité dans 1 publication.

Aperçu rapide pour EBV VCA IgG Kit ELISA (ABIN1326837)

Antigène: EBV VCA IgG (Anti-Epstein-Barr Virus Viral Capsid Antigen IgG (EBV VCA IgG))

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Competition ELISA

Application: ELISA

Type d'échantillon: Serum

Détail du produit EBV VCA IgG Kit ELISA

Fonction: Diluted patient serum is added to wells coated with purified antigen. IgG specific antibody, if present, binds to the antigen. All unbound materials are washed away and the enzyme conjugate is added to bind to the antibody-antigen complex, if present. Excess enzyme conjugate is washed off and substrate is added. The plate is incubated to allow the hydrolysis of the substrate by the enzyme. The intensity of the color generated is proportional to the amount of IgG specific antibody in the sample

Analytical Method: Qualitative

Information d'application

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Références pour EBV VCA IgG Kit ELISA (ABIN1326837)

Wang, Liu, Xu, Jackson, Roskin, Pham, Laserson, Marshall, Seo, Lee, Furman, Koller, Dekker, Davis, Fire, Boyd: "Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 2, pp. 603-11, (2014) (PubMed).

Détail du antigène

Antigène: EBV VCA IgG (Anti-Epstein-Barr Virus Viral Capsid Antigen IgG (EBV VCA IgG))

Autre désignation: EBV-VCA IgG

Classe de substances: Antibody, Antibody

Sujet: Epstein-Barr virus (EBV) is a herpes virus known to cause infectious mononucleosis (IM). EBV infection may demonstrate a wide spectrum of clinical symptoms. The majorities of primary EBV infections are transmitted via saliva, occur during childhood, and are sub-clinical. In the U.S., 50% of the population demonstrate EBV antibodies before the age of 5 years 80% by adulthood. Transfusion-associated EBV infections have also been reported. Epstein-Barr virus has also been associated in the pathogenisis of two human cancers, Burkitt's lymphoma and nasopharyngeal carcinoma. Burkitt's lymphoma is primarily observed in Sub-Sahara Africa, especially in African children, and in New Guinea. Nasopharyngeal carcinoma is observed in Asia, most notably in Southern China.